Table 1.

Sociodemographic and clinical characteristics of participants (n=165)

Mean age at baseline (s.d.), years	22.8 (8.8)
Gender
Female	76 (46.1%)
Male	89 (53.9%)
Race
White/Caucasian	74 (45.4%)
Hispanic/Latino	71 (43.6%)
Others	18 (11.0%)
Relationship status at 12 months
Married/partnered	60 (37.3%)
Not married/partnered	101 (62.7%)
Age group at diagnosis (baseline)
13–17 years	78 (47.3%)
18–25 years	32 (19.4%)
26–39 years	55(33.3%)
Type of cancer (baseline)
Hodgkin's disease	19 (11.5%)
Non-Hodgkin's lymphoma	12 (7.3%)
Testicular cancer	8 (4.9%)
Female reproductive cancers	4 (2.4%)
Soft-tissue sarcoma	19 (11.5%)
Brain	13 (7.8%)
Leukemia	43 (26.1%)
Other carcinomas	13 (7.9%)
Breast	13 (7.9%)
Bone tumors	21 (12.7%)
Severity of disease
less than 50% survival rate	54(32.7%)
50–80% survival rate	67(40.6%)
80% + survival rate	44 (26.7%)
Treatment status at 12 months
Stop treatment	85 (51.5%)
On active treatment	80 (48.5%)

s.d. = standard deviation